These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Silencing of UCA1 Protects Against MPP+-Induced Cytotoxicity in SK-N-SH Cells via Modulating KCTD20 Expression by Sponging miR-423-5p. Zheng Y, Liu J, Zhuang J, Dong X, Yu M, Li Z. Neurochem Res; 2021 Apr; 46(4):878-887. PubMed ID: 33464446 [Abstract] [Full Text] [Related]
23. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy. Schürch CM, Roelli MA, Forster S, Wasmer MH, Brühl F, Maire RS, Di Pancrazio S, Ruepp MD, Giger R, Perren A, Schmitt AM, Krebs P, Charles RP, Dettmer MS. Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231 [Abstract] [Full Text] [Related]
24. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6. Xin H, Liu N, Xu X, Zhang J, Li Y, Ma Y, Li G, Liang J. J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564 [Abstract] [Full Text] [Related]
28. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p/HGF axis. Yang Y, Chen L. J Chin Med Assoc; 2019 Sep; 82(9):699-709. PubMed ID: 31356563 [Abstract] [Full Text] [Related]
29. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. Wang C, Li X, Zhang L, Chen Y, Dong R, Zhang J, Zhao J, Guo X, Yang G, Li Y, Gu C, Xi Q, Zhang R. Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485 [Abstract] [Full Text] [Related]
30. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1. Zhang W, Ji W, Zhao X. BMC Cancer; 2019 Nov 12; 19(1):1093. PubMed ID: 31718618 [Abstract] [Full Text] [Related]
31. Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer. Gunda V, Gigliotti B, Ashry T, Ndishabandi D, McCarthy M, Zhou Z, Amin S, Lee KE, Stork T, Wirth L, Freeman GJ, Alessandrini A, Parangi S. Int J Cancer; 2019 May 01; 144(9):2266-2278. PubMed ID: 30515783 [Abstract] [Full Text] [Related]
33. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis. Zhang L, Zhang J, Li S, Zhang Y, Liu Y, Dong J, Zhao W, Yu B, Wang H, Liu J. RNA Biol; 2021 Apr 01; 18(4):547-562. PubMed ID: 32951513 [Abstract] [Full Text] [Related]
37. [Effects of lncRNA-UCA1 targeting miR-204-5p on the proliferation, migration, apoptosis and immune escape of endometrial carcinoma cells]. Jing S, Feng Y, He XL, Wang Y. Zhonghua Zhong Liu Za Zhi; 2023 Jan 23; 45(1):56-63. PubMed ID: 36709121 [Abstract] [Full Text] [Related]
38. Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis. Zhang Z, Wu X, Han Q, Huang Z. Anticancer Drugs; 2021 Jun 01; 32(6):602-613. PubMed ID: 33595944 [Abstract] [Full Text] [Related]
39. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S, Huo L, Han X, Wang J, Kong W. Cell Mol Biol Lett; 2021 Jul 08; 26(1):33. PubMed ID: 34238213 [Abstract] [Full Text] [Related]
40. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response. Zhang X, Pan B, Qiu J, Ke X, Shen S, Wang X, Tang N. Int J Exp Pathol; 2022 Jun 08; 103(3):102-111. PubMed ID: 35429078 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]